Drug Shortage Report for VANTAS
Report ID | 4358 |
Drug Identification Number | 02278383 |
Brand name | VANTAS |
Common or Proper name | HISTRELIN ACETATE |
Company Name | PALADIN PHARMA INC. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HISTRELIN ACETATE |
Strength(s) | 50MG |
Dosage form(s) | IMPLANT KIT |
Route of administration | SUBCUTANEOUS |
Packaging size | 1 vial |
ATC code | L02AE |
ATC description | HORMONES AND RELATED AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2006-07-15 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-06-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 SAINT-LAURENT, QUEBEC CANADA H4M 2P2 |
Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2017-03-27 | French | Compare |
v1 | 2017-03-27 | English | Compare |
Showing 1 to 2 of 2